biosample_id,biosample.associated_studies,material_processing_type,raw_data_file,processed_data_directory,mass_spec_configuration_name,chromat_configuration_name,instrument_used,processing_institution,instrument_analysis_start_date,instrument_analysis_end_date,execution_resource,biosample.env_medium,biosample.env_local_scale,biosample.env_broad_scale,biosample.name
,['nmdc:sty-11-34xj1150'],MPLEX,tests/test_data/test_raw_lcms_lipid/lcms_lipid_sample_1_positive.raw,tests/test_data/test_processed_lcms_lipid/lcms_lipid_sample_1_positive.corems,"EMSL lipidomics DDA mass spectrometry method, positive",EMSL LC method for non-polar metabolites,VOrbiETD04,EMSL,1/22/23,3/4/24,EMSL-RZR,ENVO:00002261,ENVO:03600011,ENVO:01000174,BW-C-30-M
,['nmdc:sty-11-34xj1150'],MPLEX,tests/test_data/test_raw_lcms_lipid/lcms_lipid_sample_1_negative.raw,tests/test_data/test_processed_lcms_lipid/lcms_lipid_sample_1_negative.corems,"EMSL lipidomics DDA mass spectrometry method, negative",EMSL LC method for non-polar metabolites,VOrbiETD04,EMSL,1/22/23,3/4/24,EMSL-RZR,ENVO:00002261,ENVO:03600011,ENVO:01000174,BW-C-30-M
,['nmdc:sty-11-e4yb9z58'],MPLEX,tests/test_data/test_raw_lcms_lipid/lcms_lipid_sample_2_positive.raw,tests/test_data/test_processed_lcms_lipid/lcms_lipid_sample_2_positive.corems,"EMSL lipidomics DDA mass spectrometry method, positive",EMSL LC method for non-polar metabolites,VOrbiETD04,EMSL,1/22/23,3/4/24,EMSL-RZR,ENVO:00002261,ENVO:03600011,ENVO:01000174,BW-C-30-M
,['nmdc:sty-11-e4yb9z58'],MPLEX,tests/test_data/test_raw_lcms_lipid/lcms_lipid_sample_2_negative.raw,tests/test_data/test_processed_lcms_lipid/lcms_lipid_sample_2_negative.corems,"EMSL lipidomics DDA mass spectrometry method, negative",EMSL LC method for non-polar metabolites,VOrbiETD04,EMSL,1/22/23,3/4/24,EMSL-RZR,ENVO:00002261,ENVO:03600011,ENVO:01000174,BW-C-30-M
